Figure 5From: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomySilencing of CIP2A in Caco-2 cells leads to decreased resistance to cetuximab. Immunoblot analysis of CIP2A expression in control (shLuc) and CIP2A knockdown (shCIP2A) cells.Back to article page